Midgard Science

Nanopharm

Cwmbran, United Kingdom nanopharm.co.uk

From their website, Nov 2026

Work here? Claim this listing

About

Nanopharm is a pharmaceutical CRO focused on developing orally inhaled and nasal drug products for small molecules and biologics. It supports customers with product development, analytical testing, in-silico modeling, regulatory consultancy, and clinical trial manufacturing services. The company is based in Cwmbran, United Kingdom, and operates as part of Aptar Pharma.

Services

  • Product Development

    Develops nasal and inhaled drug products from preformulation and preclinical work through formulation and clinical development.

  • Preformulation & Preclinical

    Studies drug substance properties, critical material attributes, excipients, solubility, stability, permeability, and preclinical models for OINDPs.

  • Spray Drying & Particle Engineering

    Uses spray drying and particle engineering to control particle size, morphology, solubility, and other powder properties for OINDPs.

  • Formulation & Drug Product Development

    Develops intranasal and inhaled formulations and combines formulation, device, and analytical studies to design complete drug products.

  • Clinical Development

    Supports progression of OINDPs into clinical stages and commercialization with cGMP-oriented development services.

  • Clinical Trial Manufacturing

    Provides clinical trial materials manufacturing support through Aptar Pharma Services' Boonton site for Phase 1 and 2 OINDP programs.

    CDMO: development & manufacturing

  • cGMP Release & Stability Testing

    Performs cGMP analytical release and stability testing for inhaled and intranasal drug products, including method development and validation.

    Assays & in vitro testing

  • Clinical Labeling

    Provides open and blinded labeling of clinical supplies for clinical studies.

  • Analytical Services

    Offers analytical development and cGMP testing for inhaled and nasal drug products, including spray characterization and method development.

    Assays & in vitro testing

  • Research & Development

    Conducts analytical R&D to characterize APIs, excipients, formulations, devices, and spray properties for OINDP development.

    Assays & in vitro testing

  • Spray Characterization

    Measures spray pattern, plume geometry, particle or droplet size distribution, delivered dose uniformity, and aerodynamic particle size distribution.

    Assays & in vitro testing

  • Method Development

    Develops and validates analytical methods for R&D and cGMP testing of nasal and inhaled drug products.

    Assays & in vitro testing

  • IVBE & CMC Studies

    Supports in-vitro bioequivalence and chemistry, manufacturing, and controls studies for OINDPs.

    Assays & in vitro testing

  • Alternative Bioequivalence

    Develops non-clinical alternative bioequivalence approaches for orally inhaled and nasal drug products.

    Assays & in vitro testing

  • In-Silico Modeling

    Uses in-silico modeling tools to simulate pharmacokinetics and regional deposition for inhaled and nasal products.

  • PBPK Modeling

    Builds physiologically based pharmacokinetic models to predict clinical PK and support OINDP development.

  • Regional Deposition Modeling

    Models regional deposition of delivered dose in the nose or lungs using in-silico tools.

  • Regulatory Consultancy

    Provides regulatory support for drug-device combination products and alternative regulatory pathways.

Capabilities

Assays and studies
Stability studies · PK/PD · Small molecules · Analytical development · Spray pattern · Plume geometry · Particle size distribution · Droplet size distribution · Delivered dose uniformity · Aerodynamic particle size distribution · Single actuation content · Dissolution
12 moreSolubility testing · Degradation pathway analysis · Compatibility testing · Pharmacokinetic simulation · Analytical testing · In-vitro testing · In-silico modeling · Pharmacokinetic simulations · Stability testing · Release testing · Method development · Spray characterization
Scale and capacity
8L pilot scale mixing and filling line · cGMP pilot scale · Phase 1 and 2 cGMP fill and finish services · cGMP cleanrooms · Phase 1 and Phase 2 clinical trial manufacturing · High-potency API suites · Biologics capabilities
Therapeutic areas
Respiratory · Nasal · Central nervous system

Instruments and platforms

  • Morphologically Directed Raman Spectroscopy (MDRS)
  • Aeronose® Nasal CAST 3D
  • SmartTrack™
  • Simhalation

Modalities and species

Modalities
Small molecule
Species and models
Preclinical or animal models · Human nasal cavity · Lungs

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: analytical testing, release and stability testing, clinical development support

Company

Type
CRO
Founded
2002

Locations

Based in
Cwmbran, United Kingdom
Sites
Cwmbran, United Kingdom · Boonton, United States · Boonton, New Jersey, United States
Serves
United Kingdom, United States, global

Contacts

Similar labs

Work here? Claim this listing